Skip to content

Emergent Biosolutions EBS Preferred Stock Par Value Per Share

Preferred Stock Par Value Per Share at other companies

CorMedix logo
CorMedixCRMD
$0.000.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$0.00
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$0.000.0%
Rapid7 logo
Rapid7RPD
$0.010.0%
Medline, Inc.
 logo
Medline, Inc. MDLN
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's preferred stock par value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's preferred stock par value per share?
Emergent Biosolutions (EBS) reported preferred stock par value per share of $0.00 in Q1 2026.
How has Emergent Biosolutions's preferred stock par value per share changed year-over-year?
Emergent Biosolutions's preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
What is the long-term trend for Emergent Biosolutions's preferred stock par value per share?
Over 5 years (2020 to 2025), Emergent Biosolutions's preferred stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
What does preferred stock par value per share mean?
The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.